Items where authors include "Webb, A."

Article

Varian, F. orcid.org/0000-0002-4644-8391, Dick, J. orcid.org/0009-0006-7959-0163, Battersby, C. et al. (35 more authors) (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14 (1). e12337. ISSN 2045-8940

Webb, A., Werring, D., Dawson, J. et al. (3 more authors) (2021) Design of a randomised, double-blind, crossover, placebo-controlled trial of effects of sildenafil on cerebrovascular function in small vessel disease: Oxford haemodynamic adaptation to reduce pulsatility trial (OxHARP). European Stroke Journal, 6 (3). pp. 283-290. ISSN 2396-9873

Rothman, A.M.K. orcid.org/0000-0002-7847-4500, MacFadyen, J., Thuren, T. et al. (6 more authors) (2020) Effects of interleukin-1β Inhibition on blood pressure, incident hypertension, and residual inflammatory risk. Hypertension, 75 (2). pp. 477-482. ISSN 0194-911X

Retzler, J. orcid.org/0000-0002-0008-3104, Hex, N., Bartlett, C. et al. (5 more authors) (2019) Economic cost of congenital CMV in the UK. Archives of Disease in Childhood (ADC), 104 (6). pp. 559-563. ISSN 0003-9888

Powles, T., Brown, J., Larkin, J. et al. (17 more authors) (2016) A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK). Annals of Oncology, 27 (5). pp. 880-886. ISSN 0923-7534

Burton, C., Linch, D., Hoskin, P. et al. (10 more authors) (2006) A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma. British Journal of Cancer, 94 (6). pp. 806-813. ISSN 0007-0920